You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沛嘉醫療-B(09996.HK)與法國醫療器械公司HighLife就經房間隔二尖瓣置換術訂立合作及許可協議
格隆匯 12-21 07:34

格隆匯 12 月 21日丨沛嘉醫療-B(09996.HK)發佈公告,2020年12月18日,公司與法國醫療器械公司HighLife SAS(HighLife或許可方)訂立許可協議,據此,HighLife已就若干現正由許可方開發中的專有經導管二尖瓣置換術(“TMVR”)產品向公司授出獨家許可。根據該協議,公司有權(其中包括)在大中華區內製造、開發及商業化有關產品,而HighLife則有權收取前期許可費及隨後里程碑付款作為回報。

HighLife開發的有關產品利用經房間隔路徑治療二尖瓣返流患者,現時在全球超過20個地方進行臨牀研究。公司認為是次合作可加入有潛力成為同類首創的臨牀階段TMVR產品,為壯大其結構性心臟產品線重要的一步,並期望可擴展有關產品在大中華區的使用,從而令更多患者受惠。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account